Real-World Effectiveness of Eptinezumab after Treatment with Subcutaneous CGRP Monoclonal Antibodies in Patients with Migraine

Casaletto, E; Yang, QZ; Waters, J; Curran, J; Lowe, A; Yuan, H

NEUROLOGY, 2023; 100 (17):